INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹192 Cr | ₹95 Cr | ₹155 Cr | ₹179 Cr | ₹174 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹192 Cr |
| Mar2025 | ₹95 Cr |
| Mar2024 | ₹155 Cr |
| Mar2023 | ₹179 Cr |
| Mar2022 | ₹174 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹192 Cr | 102.48 | |
| Mar2025 | ₹95 Cr | -38.90 | |
| Mar2024 | ₹155 Cr | -13.11 | |
| Mar2023 | ₹179 Cr | 2.88 | |
| Mar2022 | ₹174 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,137.2 Cr | -6.3% | -5.2% | -18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -6.3% |
-5.2% |
-18.5% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses